Showing results (1-10 of 518) with videos related to
Sort By:
Pageof 52
JAMA|March 10, 1999
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for StentingS R Steinhubl, W A Tan, J M Foody, et al.Circulation|March 14, 2001
Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) TrialS R Steinhubl, S G Ellis, K Wolski, et al.Heart (British Cardiac Society)|April 23, 2005
Extracardiac vascular disease and effectiveness of sustained clopidogrel treatmentD Mukherjee, E J Topol, D J Moliterno, et al.The Annals of Thoracic Surgery|August 31, 2000
Antiplatelet agents in cardiology: the choice of therapyS R SteinhublJournal of the American College of Cardiology|November 11, 1998
The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q-wave myocardial infarctionsS R Steinhubl, M S Lauer, D P Mukherjee, et al.Circulation|November 11, 1999
Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary interventionS R Steinhubl, K Kottke-Marchant, D J Moliterno, et al.The American Journal of Cardiology|December 16, 1993
Validation of the early open infarct vessel hypothesisE J TopolThe American Journal of Cardiology|September 3, 1991
Integration of anticoagulation, thrombolysis and coronary angioplasty for unstable angina pectorisE J TopolCardiology Clinics|November 1, 1989
Acute myocardial infarction: treatment with thrombolytic therapyE J TopolEuropean Heart Journal|September 1, 1996
Early myocardial reperfusion: an assessment of current strategies in acute myocardial infarctionE J TopolPageof 52